Literature DB >> 2584958

Hepatitis delta virus infections in intravenous drug abusers with hepatitis B in the west of Scotland.

E A McCruden1, E A Follett.   

Abstract

The prevalence of delta virus infection was studied in 264 intravenous drug abusers (IVDAs) whose sera were found to be HBsAg positive between 1985 and 1987 and in 15 IVDAs from the period 1971-75, seven from 1976, 15 from 1979, and 37 from 1982. Delta markers were present in 41% of IVDAs with acute hepatitis B and in 65% of those who were chronic HBsAg carriers between 1985-87. The first evidence of delta virus infection was found in 1975. In 1976, 1979, and 1982, respectively, 42, 63, and 5% of IVDAs with acute hepatitis B had delta coinfection. In the West of Scotland, delta infection has been established in the IVDA population since 1975. The very high percentage of IVDA carriers superinfected with the delta virus implies that there will be an excess of patients presenting with severe liver disease in the future.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584958     DOI: 10.1002/jmv.1890290111

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Introduction of hepatitis delta virus into Polish drug community.

Authors:  T Laskus; M Radkowski; E Lupa; J Cianciara; J Slusarczyk; G Halama; A Horban
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

2.  Hepatitis virus infection and liver disease in injecting drug users who died suddenly.

Authors:  E A McCruden; K J Hillan; I C McKay; M T Cassidy; J C Clark
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 3.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

4.  Hepatitis delta virus infection in Northern Ireland 1970-1989.

Authors:  R A Curran; H J O'Neill; J H Connolly
Journal:  Ulster Med J       Date:  1991-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.